LB7. Prospective Randomized Evaluation of DIabetics for Graft Patency and Outcomes following Coronary Artery Bypass Grafting using One versus Two or More Arterial Grafts (PREDICT Trial): Interim Analysis

Lokeswara Rao Sajja is a pioneering Cardiothoracic Surgeon in India, had his educational journey through prestigious institutions, culminating in advanced cardiovascular training under the guidance of Prof. Denton A Cooley at the Texas Heart Institute, Houston, Tx. He founded the Society of Coronary Surgeons, dedicated to advancing coronary surgery in India. As Chairman of the Sajja Heart Foundation, he received recognition as a Scientific and Industrial Research Organization (SIRO) by the Government of India in 2019. His innovative spirit led to the development of a mechanical prosthetic heart valve, eliminating the need for long-term oral anticoagulation (US and Indian patents awarded, waiting Animal implantation). He also designed the Mammary Artery Support Platform (MASP) to enhance BITA usage in CABG surgery. Dr. Sajja's surgical expertise spans around 20,000 open heart operations, and he spearheads multicenter randomized trials in Cardiac Surgery in India. His "PROMOTE Patency Study" gained global recognition as India's first multicenter randomized controlled trial in cardiac surgery. He currently leads the "PREDICT Study" with support from the Indian Council of Medical Research. He actively participates in Multi-Centre International trials in Cardiac Surgery. He is an active member of international societies, including AATS, STS, EACTS, and ASCVS, Dr. Sajja has presented numerous original research papers at international meetings. He has authored over 110 articles in peer-reviewed journals, serves as a guest reviewer for prominent journals, and holds editorial roles in respected publications. He is the Founder President of Society of Coronary Surgeons and current President of the Indian Association of Cardiovascular-Thoracic Surgeons (IACTS) 2023.